CAPITAL CLN EGY (CCEC)
(Real Time Quote from BATS)
$16.90 USD
-0.08 (-0.44%)
Updated Aug 27, 2024 02:08 PM ET
3-Hold of 5 3
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Capital Product Partners LP falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 361 | 299 | 185 | 141 | 108 |
Cost Of Goods | 101 | 84 | 58 | 45 | 33 |
Gross Profit | 260 | 215 | 127 | 96 | 75 |
Selling & Adminstrative & Depr. & Amort Expenses | 109 | 33 | 9 | 49 | 35 |
Income After Depreciation & Amortization | 151 | 183 | 118 | 47 | 40 |
Non-Operating Income | 1 | -2 | 0 | 0 | 1 |
Interest Expense | 105 | 55 | 20 | 17 | 17 |
Pretax Income | 47 | 125 | 98 | 30 | 24 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 47 | 125 | 98 | 30 | 24 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | -147 |
Net Income (GAAP) | 47 | 125 | 98 | 30 | -122 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 238 | 267 | 175 | 103 | 85 |
Depreciation & Amortization (Cash Flow) | 88 | 84 | 57 | 56 | 45 |
Income After Depreciation & Amortization | 151 | 183 | 118 | 47 | 40 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 21.18 | 19.33 | 18.34 | 18.19 | 18.18 |
Diluted EPS Before Non-Recurring Items | 2.69 | 3.86 | 2.78 | 1.60 | 0.83 |
Diluted Net EPS (GAAP) | 2.15 | 6.19 | 5.14 | 1.60 | -7.25 |
Fiscal Year end for Capital Product Partners LP falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 97.67 | 104.49 | 95.51 | 95.53 | 88.54 |
Cost Of Goods | 22.39 | 26.54 | 23.57 | 26.45 | 27.40 |
Gross Profit | 75.28 | 77.96 | 71.94 | 69.07 | 61.13 |
SG&A, R&D, and Dept/Amort Expenses | 10.69 | 11.97 | 31.49 | 24.54 | 31.17 |
Income After SG&A, R&D, and Dept/Amort Expenses | 64.59 | 65.99 | 40.45 | 44.53 | 29.96 |
Non-Operating Income | 1.01 | 1.95 | 0.18 | 0.26 | 2.95 |
Interest Expense | 31.42 | 34.04 | 27.91 | 27.76 | 25.51 |
Pretax Income | 34.18 | 33.90 | 12.73 | 17.04 | 7.41 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 34.18 | 33.90 | 12.73 | 17.04 | 7.41 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 34.18 | 33.90 | 12.73 | 17.04 | 7.41 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 54.89 | 54.82 | 25.94 | 19.46 | 19.55 |
Diluted EPS Before Non-Recurring Items | 0.40 | 0.32 | 0.61 | 0.84 | 0.36 |
Diluted Net EPS (GAAP) | 0.62 | 0.61 | 0.46 | 0.84 | 0.36 |